[ACRS] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
08-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -27.35%
YoY- -0.40%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 1,869 2,528 7,753 19,018 1,528 1,453 1,501 15.78%
PBT -29,569 -28,160 -27,635 -19,952 -20,532 -18,789 -22,804 18.96%
Tax -1,500 -1,758 5,656 1,278 -3,862 -1,318 2,003 -
NP -29,569 -26,402 -33,291 -21,230 -16,670 -17,471 -22,804 18.96%
Tax Rate - - - - - - - -
Total Cost 31,438 28,930 41,044 40,248 18,198 18,924 24,305 18.77%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -1,582.08 -1,044.38 -429.40 -111.63 -1,090.97 -1,202.41 -1,519.25 2.74%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.42 -0.39 -0.50 -0.32 -0.25 -0.28 -0.37 8.84%
EPS Diluted -0.42 -0.39 -0.50 -0.32 -0.25 -0.28 -0.37 8.84%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.